Link to this page
National Cancer Institute Thesaurus
Last uploaded:
February 23, 2024
Jump to:
Id | http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C412
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C412
|
---|---|
Preferred Name | Dactinomycin |
Definitions |
A chromopeptide antineoplastic antibiotic isolated from the bacterium Streptomyces parvulus. Dactinomycin intercalates between adjacent guanine-cytosine base pairs, blocking the transcription of DNA by RNA polymerase; it also causes single-strand DNA breaks, possibly via a free-radical intermediate or an interaction with topoisomerase II. (NCI04)
|
Synonyms |
dactinomycin
Actinomycin-[thr-val-pro-sar-meval]
Lyovac cosmegen
Actinomycin D
Actinomycin I1
ACTINOMYCIN D
Actinomycin C1
Actinomycin IV
DACTINOMYCIN
Lyovac Cosmegen
Actinomycin A IV
Dactinomycin
Dactinomycine
Meractinomycin
Actinomycin X 1
2-bis[Cyclo(N-methyl-L-valyl-sarcosyl-L-prolyl-D-valyl-L-threonyl)]-1,9 dimethyl-4,6 3H-phenoxazinone-3
Cosmegen
DACT
See more
See less
|
Type | http://www.w3.org/2002/07/owl#Class |
All Properties
label |
Dactinomycin
|
---|---|
Is_PCDC_GCT_Authorized_Value_For_Variable | |
Maps_To |
Dactinomycin
|
Accepted_Therapeutic_Use_For |
Wilms' tumor; rhabdomyosarcoma; Ewing's sarcoma; testicular cancer; gestational trophoblastic neoplasia; choriocarcinoma; melanoma; neuroblastoma; retinoblastoma; uterine sarcomas; Kaposi's sarcoma; sarcoma botryoides; soft tissue sarcoma.
|
Legacy Concept Name |
Dactinomycin
|
CHEBI_ID |
CHEBI:27666
|
NCI_Drug_Dictionary_ID |
39675
|
Is_Value_For_GDC_Property | |
PDQ_Closed_Trial_Search_ID |
39675
|
Preferred_Name |
Dactinomycin
|
Display_Name |
Dactinomycin
|
Semantic_Type |
Amino Acid, Peptide, or Protein
Pharmacologic Substance
Antibiotic
|
prefixIRI |
Thesaurus:C412
|
DEFINITION |
A chromopeptide antineoplastic antibiotic isolated from the bacterium Streptomyces parvulus. Dactinomycin intercalates between adjacent guanine-cytosine base pairs, blocking the transcription of DNA by RNA polymerase; it also causes single-strand DNA breaks, possibly via a free-radical intermediate or an interaction with topoisomerase II. (NCI04)
|
UMLS_CUI |
C0010934
|
code |
C412
|
Chemical_Formula |
C62H86N12O16
|
subClassOf | |
NSC Number |
3053
|
type | |
CAS_Registry |
50-76-0
|
FULL_SYN |
dactinomycin
Actinomycin-[thr-val-pro-sar-meval]
Lyovac cosmegen
Actinomycin D
Actinomycin I1
ACTINOMYCIN D
Actinomycin C1
Actinomycin IV
DACTINOMYCIN
Lyovac Cosmegen
Actinomycin A IV
Dactinomycin
Dactinomycine
Meractinomycin
Actinomycin X 1
2-bis[Cyclo(N-methyl-L-valyl-sarcosyl-L-prolyl-D-valyl-L-threonyl)]-1,9 dimethyl-4,6 3H-phenoxazinone-3
Cosmegen
DACT
See more
See less
|
FDA_UNII_Code |
1CC1JFE158
|
ALT_DEFINITION |
An anticancer drug that is a type of antitumor antibiotic.
|
PDQ_Open_Trial_Search_ID |
39675
|
Contributing_Source |
CTRP
FDA
GDC
HemOnc
PCDC
|
Concept_In_Subset |
See more
See less
|
Add comment
Delete | Subject | Author | Type | Created |
---|---|---|---|---|
No notes to display |